Pfizer Inc’s partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new production lines and as more doses can be extracted per vial.
Source: ctv business
BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion

